Spector, S., Weingeist, T., Pollard, R.B., et al. A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J. Infect. Dis. 1993; 168:557-560.
Dieterich D.T., Poles, M.A., Lew, E.A., et al. Concurrentl use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J. Infect. Dis. 1993; 167: 1184-1188.
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. 4. Visual Outcomes. Ophthalmology. 1994; 101: 1250-1261.
Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial-3. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch. Int. Med. 1995;155: 65-74.
Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-GanciclovirCytomegalovirus Retinitis Trial-4. Visual outcomes. Ophthalmology.1994; 101: 1250-1261.
Department of Medicine Faculty Listing
Adjunct Professor, Department of Medicine
MD from New York University
Gastroenterology. 2017 May; 152(6):1544-1577
Liver international. 2017 May; 37(5):662-668
American journal of managed care. 2017 Feb; 23(2):107-112
Journal of viral hepatitis. 2017 Jan; 24(1):22-27
Hepatology. 2016 Dec; 64(6):1893-1899
Case Series: Change in Genotype in Patients with Chronic Hepatitis C [Meeting Abstract]
American journal of gastroenterology. 2016 OCT; 111:S1360-S1360
Medicine (Baltimore). 2016 Oct; 95(41):e5048-e5048e5048
Effect of ethnicity on HCV patient outcomes and access to therapy in era of all DAA regimens: Real-world experience from the trio network [Meeting Abstract]
Hepatology. 2016 Oct; Conference:(67th):1006A-1007A